+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NGS-Based RNA-Sequencing Market by Application, Product, End User, Workflow, Technology - Global Forecast to 2030- Product Image
NGS-Based RNA-Sequencing Market by Application, Product, End User, Workflow, Technology - Global Forecast to 2030- Product Image
Sale

NGS-Based RNA-Sequencing Market by Application, Product, End User, Workflow, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533389
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The NGS-Based RNA-Sequencing Market grew from USD 2.67 billion in 2024 to USD 3.17 billion in 2025. It is expected to continue growing at a CAGR of 17.75%, reaching USD 7.13 billion by 2030.

Unveiling the Power of RNA Sequencing Revolution

Next-generation RNA sequencing has emerged as a transformative force in molecular biology, ushering in a new era of precision and depth in transcriptomic analysis By enabling comprehensive profiling of gene expression patterns, alternative splicing events, and non-coding RNA landscapes, RNA sequencing transcends the limitations of traditional methods and drives a profound shift in research, diagnostics, and therapeutics Throughout this report, we examine the pivotal technologies, market dynamics, and strategic implications that define the current state of RNA sequencing, delving into the key drivers and challenges shaping its widespread adoption

Transformative Shifts Redefining the RNA Sequencing Landscape

The RNA sequencing ecosystem is undergoing rapid evolution as technological breakthroughs and converging disciplines forge novel capabilities Where short-read sequencing once dominated, the advent of long-read platforms and single-cell resolution methods is expanding the boundaries of what can be observed at the molecular level Innovations in spatial transcriptomics are now fusing the high-throughput capacity of RNA sequencing with precise localization of gene expression within intact tissues, thereby creating opportunities for more accurate disease characterization and targeted therapeutic interventions As automated library preparation systems and integrated data analysis pipelines proliferate, end users are able to streamline workflows, reduce hands-on time and accelerate time-to-insight, transforming laboratory operations and enabling scalable adoption across diverse research and clinical settings

Assessing the Cumulative Impact of 2025 US Tariffs

The introduction of heightened US tariffs in 2025 has introduced a complex set of cost considerations for global stakeholders in the RNA sequencing market As import duties on critical equipment, consumables and reagents rose, laboratories and service providers faced pressure to reassess sourcing strategies and supply chain resilience Many suppliers have responded by localizing production, diversifying supplier portfolios and renegotiating contractual terms to mitigate margin erosion and maintain competitive pricing for end users At the same time, the speculative impact on downstream research budgets has driven increased collaboration between academic institutions and industry partners, fostering joint ventures that pool resources and expertise This collaborative model has partially offset the cost burden imposed by tariffs, enabling continued investment in high-value sequencing initiatives while navigating a more restrictive trade environment

Decoding Key Segmentation Insights for Strategic Clarity

An examination of market segmentation reveals a tapestry of applications, product types, end user profiles, workflows and underpinning technologies Each segment represents a constellation of unmet needs and growth potential Within the application domain, biomarker discovery stands out by encompassing both early-stage biomarker identification and subsequent validation phases that underpin translational research. Complementing this, drug discovery and development efforts leverage pharmacokinetic studies, target identification and toxicology studies to de-risk candidate selection and accelerate clinical pipelines. Gene expression profiling is bifurcated into bulk approaches, single-cell resolution and spatially informed analyses, enabling researchers to dissect heterogeneity at unprecedented granularity. Personalized medicine initiatives are underpinned by companion diagnostics and therapeutic monitoring frameworks that ensure tailored treatment regimens. From a product perspective, consumables such as enzymes, reagents and kits form the backbone of routine workflows, while instruments spanning library preparation systems, sequencers and data analysis platforms deliver scalable performance. Services including sample preparation, bioinformatics analysis and project management are augmenting in-house capabilities, giving rise to hybrid service models favored by resource-constrained laboratories. End users range from academic and government research institutes and universities to hospital and independent diagnostic laboratories, contract research organizations, and biotechnology and pharmaceutical companies, each demanding customized solutions. The workflow spectrum extends from RNA extraction and tissue dissociation to adapter ligation, amplification, barcoding and fragmentation in library preparation, followed by high-throughput or low-throughput sequencing and culminating in alignment, mapping, differential expression and functional annotation tasks. Underlying these activities, technology innovations such as bulk sequencing, long-read platforms, single-cell approaches and spatial transcriptomics are driving segmentation-specific strategies, with each technology offering distinct advantages in terms of throughput, resolution and contextual insights

Regional Dynamics Shaping Global RNA Sequencing Trends

Regional dynamics are shaping divergent growth trajectories across the RNA sequencing market In the Americas, particularly North America, robust academic research funding, a concentration of large-scale genome centers and early adoption of emerging technologies continue to anchor the region as a global innovation powerhouse Latin American markets are gradually expanding as government-led precision medicine initiatives gain traction. In Europe, Middle East & Africa, heterogeneous regulatory landscapes and varying levels of infrastructure maturity are driving strategic partnerships and public-private consortia that aim to harmonize standards and scale up translational research. Clinical adoption in hospital laboratories across Europe is rising in response to regulatory support for genomics in diagnostics, while research institutes in the Middle East are prioritizing local capacity building. The Asia-Pacific region is characterized by ambitious national genomics programs, particularly in countries investing heavily in precision oncology and agricultural biotechnology. Rapid expansion of contract research organizations, coupled with targeted incentives for biotechnology investment, is catalyzing wider adoption of advanced sequencing platforms and associated bioinformatics services across the region

Key Corporate Strategies Driving Market Leadership

Leading companies in the RNA sequencing landscape are leveraging integrated portfolios, strategic alliances and aggressive R&D pipelines to consolidate market share and differentiate their offerings Firms with end-to-end solutions are bundling advanced sequencers with proprietary reagents, automated library preparation modules and cloud-based data analytics environments to deliver turnkey systems that reduce time-to-results. Others are forming partnerships with specialist bioinformatics providers to enrich their service offerings and support clients through complex data interpretation challenges. Emerging players are carving niches by focusing on single-cell and spatial transcriptomics platforms with user-friendly interfaces and modular scalability. Collaborative ventures between instrument manufacturers and semiconductor chip designers are accelerating throughput innovations, while established reagent suppliers are expanding into enzyme engineering to enhance reaction efficiency. Amid this competitive landscape, strategic investments in service networks, training programs and digital ecosystems are becoming critical differentiators for retaining key customers and unlocking new revenue streams

Actionable Recommendations to Seize Emerging Opportunities

Industry leaders should prioritize investment in integrated solutions that seamlessly bridge laboratory and computational workflows, thereby enhancing user experience and reducing operational complexity. Strengthening partnerships with academic and clinical research consortia will facilitate early access to real-world data sets and accelerate validation of novel applications. To mitigate supply chain disruptions and cost pressures, establishing redundant manufacturing hubs across multiple geographies and fostering local supplier ecosystems will be essential. Expanding training and support services tailored to diverse end user expertise levels will drive adoption, especially for advanced modalities such as single-cell and spatial analyses. Strategic acquisitions of specialized bioinformatics firms can augment in-house capabilities and streamline data interpretation pipelines. Finally, aligning product development roadmaps with emerging regulatory frameworks and reimbursement pathways will ensure market readiness and foster long-term commercial sustainability

Robust Research Methodology Ensuring Analytical Rigor

This report is underpinned by a multifaceted research framework that combines primary interviews, secondary data analysis and expert validation phases. Primary research involved in-depth conversations with key opinion leaders, laboratory directors and procurement executives to capture firsthand perspectives on unmet needs and investment priorities. Secondary research encompassed a rigorous review of peer-reviewed literature, patent filings, regulatory filings and industry white papers to map technological trajectories and competitive positioning. Data triangulation techniques were applied to reconcile divergent inputs and enhance analytical robustness. Quantitative assessments of market trends were informed by historical adoption rates, installed base dynamics and technology migration patterns. Qualitative insights were validated through a panel of external advisors, ensuring that interpretations align with practical realities and evolving scientific paradigms. This comprehensive methodology ensures that findings are both actionable and deeply rooted in empirical evidence

Concluding Insights on Future Trajectories and Innovations

In conclusion, next-generation RNA sequencing stands at the cusp of widespread clinical integration and transformative scientific discovery The convergence of high-resolution technologies, scalable workflows and advanced analytics is redefining the boundaries of transcriptomic research and ushering in an era of precision diagnostics and personalized therapeutics While market dynamics such as trade policies and competitive pressures present challenges, they also spur innovation in supply chain optimization and collaborative ecosystems The strategic interplay between segmentation-specific demand, regional priorities and corporate initiatives will shape the trajectory of the market over the coming years, creating fertile ground for innovation and value creation

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Biomarker Discovery
      • Early-Stage Biomarker Identification
      • Validation
    • Drug Discovery & Development
      • Pharmacokinetic Studies
      • Target Identification
      • Toxicology Studies
    • Gene Expression Profiling
      • Bulk Profiling
      • Single-Cell Profiling
      • Spatial Profiling
    • Personalized Medicine
      • Companion Diagnostics
      • Therapeutic Monitoring
  • Product
    • Consumables
      • Enzymes
      • Reagents And Kits
    • Instruments
      • Data Analysis Platforms
      • Library Prep Instruments
      • Sequencers
    • Services
      • Bioinformatics Analysis Services
      • Project Management Services
      • Sample Preparation Services
  • End User
    • Academic & Government
      • Research Institutes
      • Universities
    • Clinical Diagnostics Laboratories
      • Hospital Laboratories
      • Independent Laboratories
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
      • Biotechnology Companies
      • Pharmaceutical Companies
  • Workflow
    • Data Analysis
      • Alignment & Mapping
      • Data Management
      • Differential Expression Analysis
      • Functional Annotation
    • Library Preparation
      • Adapter Ligation
      • Amplification
      • Barcoding
      • Fragmentation
    • Sample Preparation
      • RNA Extraction
      • Tissue Dissociation
    • Sequencing
      • High-Throughput Sequencing
      • Low-Throughput Sequencing
  • Technology
    • Bulk Sequencing
    • Long-Read Sequencing
    • Single-Cell Sequencing
    • Spatial Transcriptomics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • PerkinElmer, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. NGS-Based RNA-Sequencing Market, by Application
8.1. Introduction
8.2. Biomarker Discovery
8.2.1. Early-Stage Biomarker Identification
8.2.2. Validation
8.3. Drug Discovery & Development
8.3.1. Pharmacokinetic Studies
8.3.2. Target Identification
8.3.3. Toxicology Studies
8.4. Gene Expression Profiling
8.4.1. Bulk Profiling
8.4.2. Single-Cell Profiling
8.4.3. Spatial Profiling
8.5. Personalized Medicine
8.5.1. Companion Diagnostics
8.5.2. Therapeutic Monitoring
9. NGS-Based RNA-Sequencing Market, by Product
9.1. Introduction
9.2. Consumables
9.2.1. Enzymes
9.2.2. Reagents and Kits
9.3. Instruments
9.3.1. Data Analysis Platforms
9.3.2. Library Prep Instruments
9.3.3. Sequencers
9.4. Services
9.4.1. Bioinformatics Analysis Services
9.4.2. Project Management Services
9.4.3. Sample Preparation Services
10. NGS-Based RNA-Sequencing Market, by End User
10.1. Introduction
10.2. Academic & Government
10.2.1. Research Institutes
10.2.2. Universities
10.3. Clinical Diagnostics Laboratories
10.3.1. Hospital Laboratories
10.3.2. Independent Laboratories
10.4. Contract Research Organizations
10.5. Pharmaceutical & Biotechnology Companies
10.5.1. Biotechnology Companies
10.5.2. Pharmaceutical Companies
11. NGS-Based RNA-Sequencing Market, by Workflow
11.1. Introduction
11.2. Data Analysis
11.2.1. Alignment & Mapping
11.2.2. Data Management
11.2.3. Differential Expression Analysis
11.2.4. Functional Annotation
11.3. Library Preparation
11.3.1. Adapter Ligation
11.3.2. Amplification
11.3.3. Barcoding
11.3.4. Fragmentation
11.4. Sample Preparation
11.4.1. RNA Extraction
11.4.2. Tissue Dissociation
11.5. Sequencing
11.5.1. High-Throughput Sequencing
11.5.2. Low-Throughput Sequencing
12. NGS-Based RNA-Sequencing Market, by Technology
12.1. Introduction
12.2. Bulk Sequencing
12.3. Long-Read Sequencing
12.4. Single-Cell Sequencing
12.5. Spatial Transcriptomics
13. Americas NGS-Based RNA-Sequencing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific NGS-Based RNA-Sequencing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. QIAGEN N.V.
16.3.4. Pacific Biosciences of California, Inc.
16.3.5. Oxford Nanopore Technologies Ltd.
16.3.6. BGI Genomics Co., Ltd.
16.3.7. F. Hoffmann-La Roche Ltd
16.3.8. Agilent Technologies, Inc.
16.3.9. Eurofins Scientific SE
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET MULTI-CURRENCY
FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET MULTI-LANGUAGE
FIGURE 3. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EARLY-STAGE BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BULK PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-CELL PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SPATIAL PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREP INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOINFORMATICS ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PROJECT MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ALIGNMENT & MAPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DIFFERENTIAL EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY FUNCTIONAL ANNOTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ADAPTER LIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BARCODING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY FRAGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LOW-THROUGHPUT SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BULK SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LONG-READ SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 120. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 122. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 123. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 124. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 125. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 127. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 131. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 132. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 133. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 134. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 135. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 136. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 137. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 138. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 141. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 142. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 143. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 144. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 147. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 150. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 153. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 155. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 156. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 157. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 237. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 238. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 239. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 242. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 244. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 246. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 247. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 248. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 249. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 250. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 251. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 252. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 253. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 256. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 257. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 258. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 261. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 263. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 265. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 266. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 267. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 268. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 269. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 270. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 271. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 272. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 286. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 294. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 295. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2018-2030 (USD MILLION)
TABLE 296. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 297. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 299. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 300. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 301. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ACADEMIC & GOVERNMENT, 2018-2030 (USD MILLION)
TABLE 303. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, 2018-2030 (USD MILLION)
TABLE 304. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 305. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 306. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 307. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, 2018-2030 (USD MILLION)
TABLE 308. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 309. ITALY NGS

Companies Mentioned

The companies profiled in this NGS-Based RNA-Sequencing market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.13 Billion
Compound Annual Growth Rate17.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report by Product & Service (Consumables, Instruments, Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Application, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report by Product & Service (Consumables, Instruments, Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Application, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast to 2030 - Product Image

NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast to 2030 - Product Image

Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030 - Product Image

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Next Generation RNA Sequencing Market

The Next Generation RNA Sequencing (NGS) market is a rapidly growing segment of the genomics industry. NGS is a powerful tool for studying gene expression, which is the process by which genetic information is used to produce proteins and other molecules. NGS enables researchers to analyze the expression of thousands of genes simultaneously, providing a comprehensive view of gene expression in a single experiment. This technology has been used to study a wide range of biological processes, including cancer, neurological disorders, and infectious diseases. NGS has also been used to identify novel biomarkers and therapeutic targets, as well as to develop personalized medicine. In addition, NGS has enabled researchers to study the evolution of genes and to identify genetic variants associated with disease. Companies in the Next Generation RNA Sequencing market include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, and 10X Genomics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.